• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Kailera Therapeutics, Inc. - Common stock (NQ:KLRA)

    12.85 -0.56 (-4.18%)
    Delayed Quote Updated: 11:39 AM EDT, Oct 30, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about Kailera Therapeutics, Inc. - Common stock

    News headline image
    Kailera Therapeutics to Participate in September Investor Conferences
    From Kailera Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Kailera Reports Second Quarter 2026 Financial Results and Provides Business Updates
    From Kailera Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Kailera Therapeutics Appoints Nur Nicholson as Chief Technology Officer
    Veteran technical operations executive to lead manufacturing and supply chain strategy as company advances late-stage obesity pipeline toward commercialization 
    From Kailera Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Kailera Therapeutics Announces Positive Topline Data from Two Hengrui Pharma Phase 3 Clinical Trials of Oral Small Molecule GLP-1 Receptor Agonist HRS-7535/KAI-7535
    From Kailera Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Kailera Therapeutics to Present at the 2026 Jefferies Global Healthcare Conference
    From Kailera Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Kailera Reports First Quarter 2026 Financial Results and Provides Clinical Data Updates
    From Kailera Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Kailera Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
    From Kailera Therapeutics, Inc.
    Via GlobeNewswire
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.